Cooper DA - Search Results

1

Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor.

Carr A, Cooper DA. Carr A, et al. Among authors: cooper da. Lancet. 1997 Apr 5;349(9057):995-6. doi: 10.1016/S0140-6736(05)62892-9. Lancet. 1997. PMID: 9100629 No abstract available.

2

HIV protease inhibitors.

Carr A, Cooper DA. Carr A, et al. Among authors: cooper da. AIDS. 1996;10 Suppl A:S151-7. doi: 10.1097/00002030-199601001-00021. AIDS. 1996. PMID: 8883623 Review. No abstract available.

3

Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes.

Zaunders J, Carr A, McNally L, Penny R, Cooper DA. Zaunders J, et al. Among authors: cooper da. AIDS. 1995 Jun;9(6):561-6. doi: 10.1097/00002030-199506000-00005. AIDS. 1995. PMID: 7662193

4

Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients.

Carr A, Gross AS, Hoskins JM, Penny R, Cooper DA. Carr A, et al. Among authors: cooper da. AIDS. 1994 Mar;8(3):333-7. doi: 10.1097/00002030-199403000-00006. AIDS. 1994. PMID: 8031511

5

Patterns of multiple-drug hypersensitivities in HIV-infected patients.

Carr A, Tindall B, Penny R, Cooper DA. Carr A, et al. Among authors: cooper da. AIDS. 1993 Nov;7(11):1532-3. doi: 10.1097/00002030-199311000-00023. AIDS. 1993. PMID: 8280426 No abstract available.

6

Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response.

Tindall B, Carr A, Goldstein D, Penny R, Cooper DA. Tindall B, et al. Among authors: cooper da. AIDS. 1993 Jan;7(1):127-8. doi: 10.1097/00002030-199301000-00020. AIDS. 1993. PMID: 8442903 No abstract available.

7

Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.

Carr A, Penny R, Cooper DA. Carr A, et al. Among authors: cooper da. AIDS. 1993 Jan;7(1):65-71. doi: 10.1097/00002030-199301000-00010. AIDS. 1993. PMID: 8442919

8

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.

Kelleher AD, Carr A, Zaunders J, Cooper DA. Kelleher AD, et al. Among authors: cooper da. J Infect Dis. 1996 Feb;173(2):321-9. doi: 10.1093/infdis/173.2.321. J Infect Dis. 1996. PMID: 8568292 Clinical Trial.

9

A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group.

Carr A, Vella S, de Jong MD, Sorice F, Imrie A, Boucher CA, Cooper DA. Carr A, et al. Among authors: cooper da. AIDS. 1996 Jun;10(6):635-41. doi: 10.1097/00002030-199606000-00009. AIDS. 1996. PMID: 8780818 Clinical Trial.

10

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.

Carr A, Cooper DA. Carr A, et al. Among authors: cooper da. Lancet. 1997 Aug 23;350(9077):589; author reply 590. doi: 10.1016/S0140-6736(05)63175-3. Lancet. 1997. PMID: 9284795 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

830 results

Search Page

Filters